Advanced stage mucinous adenocarcinoma of the ovary is both rare and highly lethal

Cancer

Volumn 117, Issue 3, 2011, Pages 554-562

  Zaino, Richard J ^a   Brady, Mark F ^b   Lele, Subodh M ^c   Michael, Helen ^d   Greer, Benjamin ^e   Bookman, Michael A ^f  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d INDIANA UNIVERSITY   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

^f FOX CHASE CANCER CENTER   (United States)

Author keywords

adenocarcinoma; carcinoma; metastasis; mucinous; ovary; survival; therapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVANCED CANCER; ARTICLE; CANCER STAGING; COLLOID CARCINOMA; CYTOREDUCTIVE SURGERY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LETHALITY; MAJOR CLINICAL STUDY; OVARY ADENOCARCINOMA; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RARE DISEASE; REPRODUCIBILITY; TUMOR CLASSIFICATION;

ADENOCARCINOMA, MUCINOUS; ALGORITHMS; CYSTADENOCARCINOMA, SEROUS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; OVARIAN NEOPLASMS;

EID: 79251498945     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25460     Document Type: Article

References (35)

1. Hart W, Norris H., Borderline and malignant mucinous tumors of the ovary. Cancer 1973; 31: 1031-1045.
2. Hart WR., Diagnostic challenge of secondary (metastatic) ovarian tumors simulating primary endometrioid and mucinous neoplasms. Pathol Int. 2005; 55: 231-243.
3. Seidman JD, Kurman RJ, Ronnett BM., Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis. Am J Surg Pathol. 2003; 27: 985-993.
4. Daya D, Nazerali L, Frank GL., Metastatic ovarian carcinoma of large intestinal origin simulating primary ovarian carcinoma. A clinicopathologic study of 25 cases. Am J Clin Pathol. 1992; 97: 751-758.
5. Elishaev E, Gilks CB, Miller D, et al. Synchronous and metachronous endocervical and ovarian neoplasms: evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinomas simulating primary ovarian surface epithelial neoplasms. Am J Surg Path. 2005; 29: 281-294.
6. Hart WR., Mucinous tumors of the ovary: a review. Int J Gynecol Pathol. 2005; 24: 4-5.
7. Ji H, Isacson C, Seidman JD, et al. Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous c arcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas. Int J Gynecol Pathol. 2002; 21: 391-400.
8. Lash RH, Hart WR., Intestinal adenocarcinomas metastatic to the ovaries. A clinicopathologic evaluation of 22 cases. Am J Surg Pathol. 1987; 11: 114-121.
9. Lee KR, Young RH., The distinction between primary and metastatic mucinous carcinomas of the ovary: gross and histologic findings in 50 cases. Am J Surg Pathol. 2003; 27: 281-292.
10. Lerwill MF, Young RH., Ovarian metastases of intestinal-type gastric carcinoma: a clinicopathologic study of 4 cases with contrasting features to those of the Krukenberg tumor. Am J Surg Pathol. 2006; 30: 1382-1388.
11. Lewis MR, Deavers MT, Silva EG, et al. Ovarian involvement by metastatic colorectal adenocarcinoma: still a diagnostic challenge. Am J Surg Pathol. 2006; 30: 177-184.
12. Prat J., Ovarian carcinomas, including secondary tumors: diagnostically challenging areas. Mod Pathol. 2005; 18 (suppl 2): S99-S111.
13. Ronnett BM, Shmookler BM, Diener-West M, et al. Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women. Int J Gynecol Pathol. 1997; 16: 1-9.
14. Ulbright TM, Roth LM, Stehman FB., Secondary ovarian neoplasia. A clinicopathologic study of 35 cases. Cancer 1984; 53: 1164-1174.
15. Young RH., From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary: part 1. Historical perspective, general principles, mucinous tumors including the Krukenberg tumor. Adv Anat Pathol. 2006; 13: 205-227.
16. Young RH, Scully RE., Ovarian metastases from carcinoma of the gallbladder and extrahepatic bile ducts simulating primary tumors of the ovary. A report of six cases. Int J Gynecol Pathol. 1990; 9: 60-72.
17. Albarracin CT, Jafri J, Montag AG, et al. Differential expression of MUC2 and MUC5AC mucin genes in primary ovarian and metastatic colonic carcinoma. Hum Pathol. 2000; 31: 672-677.
18. Chou YY, Jeng YM, Kao HL, et al. Differentiation of ovarian mucinous carcinoma and metastatic colorectal adenocarcinoma by immunostaining with beta-catenin. Histopathology 2003; 43: 151-156.
19. Logani S, Oliva E, Arnell PM, et al. Use of novel immunohistochemical markers expressed in colonic adenocarcinoma to distinguish primary ovarian tumors from metastatic colorectal carcinoma. Mod Pathol. 2005; 18: 19-25.
20. McCluggage WG, Young RH., Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors. Semin Diagn Pathol. 2005; 22: 3-32.
21. Riopel MA, Ronnett BM, Kurman RJ., Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas. Am J Surg Pathol. 1999; 23: 617-635.
22. Vang R, Gown AM, Barry TS, et al. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases. Am J Surg Pathol. 2006; 30: 1130-1139.
23. Yemelyanova A, Vang R, Judson K, et al. Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality by primary site with reevaluation of an algorithm for tumor classification. Am J Surg Pathol. 2008; 32: 128-138.
24. Kikkawa F, Nawa A, Kajiyama H, et al. Clinical characteristics and prognosis of mucinous tumors of the ovary. Gynecol Oncol. 2006; 103: 171-175.
25. Chaitin B, Gershenson D, Evans H., Mucinous tumors of the ovary. Cancer 1985; 55: 1958-1962.
26. Seidman JD, Horkayne-Szakaly I, Haiba M, et al. The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin. Int J Gynecol Pathol. 2004; 23: 41-44.
27. Fisher RA., The logic of inductive inference. J R Stat Soc. 1935; 98: 39-82.
28. Mantel N., Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966; 50: 163-170.
29. Kaplan EL, Meier P., Nonparametric estimation from incomplete observations. J Amer Stat Assoc. 1958; 53: 457-481.
30. Ronnett BM, Kurman RJ, Shmookler BM, et al. The morphologic spectrum of ovarian metastases of appendiceal adenocarcinomas: a clinicopathologic and immunohistochemical analysis of tumors often misinterpreted as primary ovarian tumors or metastatic tumors from other gastrointestinal sites. Am J Surg Pathol. 1997; 21: 1144-1155.
31. Baker P, Oliva E., Immunohistochemistry as a tool in the differential diagnosis of ovarian tumors: an update. Int J Gynecol Pathol. 2004; 24: 39-55.
32. Rodriguez I, Prat J., Mucinous tumors of the ovary: a clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas. Am J Surg Pathol. 2002; 26: 139-152.
33. Hoerl HD, Hart WR., Primary ovarian mucinous cystadenocarcinomas: a clinicopathologic study of 49 cases with long-term follow-up. Am J Surg Pathol. 1998; 22: 1449-1462.
34. Lee KR, Scully R., Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with 'pseudomyxoma peritonei'. Am J Surg Pathol. 2000; 24: 1447-1464.
35. Hess V, A'Hern R, Nasiri N, et al. Mucinous epithelial ovarian cancer: a separate entity requiring specific treatment. J Clin Oncol. 2004; 22: 1040-1044.